Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epogen and Restrictive Transfusions in Cardiac Surgery
NCT02802592Phase 2Terminated
- Sponsor
- Johns Hopkins University
- Start
- May 2015
- Primary completion
- Jun 2016
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of epoetin alfa in anemia (2 arms), sponsored by Johns Hopkins University. Primary endpoint: Total Number of Packed Red Blood Cells Transfused During the Intraoperative and Immediate Postoperative Period. Started May 2015; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02802592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02802592.